CDKL5 Deficiency Disorder clinical trials at UC Health
1 research study open to eligible people

• Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder

  open to eligible people ages 2-21

  A clinical study to evaluate the efficacy, safety, and tolerability of adjunctive ganaxolone therapy compared to placebo for the treatment of seizures in children and young adults with genetically confirmed CDKL5 gene mutation.

  at UCLA

Last updated: June 1, 2019